Back to News
Market Impact: 0.2
Bavarian Nordic udnævner Tarja Stenvall til administrerende direktør
Source: GlobeNewswire
Management & GovernanceHealthcare & Biotech
Bavarian Nordic appointed Tanja Stenvall as CEO effective October 15, 2026, succeeding Paul Chaplin following his previously announced departure. The announcement provides leadership-transition clarity for the Danish biotech company but includes no financial, operational, or strategic guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
BAVA0.15
More News
- Bavarian Nordic wins UK contract for mpox and smallpox vaccine
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Adeia earnings on deck: Can diversification offset Pay-TV woes?
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution